Provident Bancorp Investor Alert: Kaplan Fox Investigates Provident Bancorp
November 25, 2022 11:56 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 25, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Provident Bancorp, Inc. (“Provident” or “Company”)...
Kaplan Fox Continues to Investigate Potential Securities Fraud at Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) - INVESTOR UPDATE
November 25, 2022 10:59 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 25, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing to investigate claims on behalf of investors in Spectrum Pharmaceuticals, Inc....
DLocal Limited Shareholder Alert: Kaplan Fox is Investigating Potential Securities Fraud (DLO)
November 23, 2022 16:59 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of DLocal Limited (“DLocal”) (NASDAQ: DLO). If you...
Kaplan Fox Investigates Potential Securities Fraud at Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)
November 21, 2022 18:16 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...
FIGS INVESTOR ALERT: Kaplan Fox & Kilshiemer LLP Notifies FIGS Investors of a Class Action Lawsuit and Upcoming Deadline
November 16, 2022 13:45 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of FIGS Inc. (NYSE: FIGS). A class action complaint...
SPPI Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Spectrum Pharmaceuticals, Inc.
November 11, 2022 20:00 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...
FRESHWORKS INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Freshworks Investors of a Class Action Lawsuit and Upcoming Deadline
November 10, 2022 17:54 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.Kaplanfox.com) is investigating claims on behalf of investors of Freshworks Inc. (NASDAQ: FRSH). A class action...
Fulgent Genetics’s Investor Alert: Kaplan Fox Reminds Investors of an Important Deadline
November 09, 2022 11:35 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a securities class action case has been brought against Fulgent Genetics, Inc....
Y-mAbs Therapeutics, Inc. Shareholder Alert: Kaplan Fox Investigates Potential Securities Fraud
November 04, 2022 09:00 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the...
Spectrum Pharmaceuticals, Inc. Shareholder Alert: Kaplan Fox Investigates Potential Securities Fraud
November 03, 2022 17:16 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...